Fig. 2From: Evaluation of survivin expression in prostate specimens of patients with prostate adenocarcinoma and benign prostate hyperplasia underwent transurethral resection of the prostate or prostatectomySurvivin expression percentage levels in different histopathological groups of prostate samplesBack to article page